For instance, studies have linked reduced serum myostatin levels to the progression of genetic muscle disease [54], possibly attributed to the downregulation of the myostatin pathway as a compensatory mechanism in response to muscle wasting or atrophy [55]. This evidence concerns the gene MSTN and hereditary skeletal muscle disorder.